Investigating The effect of melatonin on serum changes of Adropin in patients with diabetic retinopathy

Not Applicable

Recruiting

• Conditions: Diabetic Retinopathy.; Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy; E08.311

• Registration Number: IRCT20211222053481N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Patients with diabetic retinopathy
Patients without a history of melatonin use
Age range 65 to 75 years

Exclusion Criteria

History of melatonin use
History of using antioxidant compounds such as doxium
Has not consumed the essential elements with antioxidant properties
Antioxidant vitamins such as vitamins C and E.Not consumed

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum changes of Adropin. Timepoint: Measurement of serum Adropin levels before intervention and 60 days after melatonin administration. Method of measurement: ELISA Method.